San Diego, CA, United States of America

Laxman Eltepu

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Laxman Eltepu: Innovator in Immunomodulating Technologies

Introduction

Laxman Eltepu is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of immunomodulating technologies. With a total of five patents to his name, he has made remarkable advancements in the synthesis and application of immunomodulating polynucleotides.

Latest Patents

Eltepu's latest patents include groundbreaking work on immunomodulating polynucleotides and antibody conjugates. These polynucleotides may contain 5-modified uridine and 5-modified cytidine, with a total length ranging from six to sixteen nucleotides. His patents also describe conjugates that incorporate a targeting moiety along with one or more immunomodulating polynucleotides. Additionally, he has developed pharmaceutical compositions that utilize these innovative polynucleotides and conjugates, enhancing their therapeutic potential.

Career Highlights

Throughout his career, Laxman Eltepu has worked with notable companies such as Sirius Therapeutics, Inc. and Tollnine, Inc. His expertise in the field has allowed him to contribute to various projects that focus on the development of advanced therapeutic solutions.

Collaborations

Eltepu has collaborated with esteemed colleagues, including Sukumar Sakamuri and Curt William Bradshaw, to further enhance the impact of his inventions in the scientific community.

Conclusion

Laxman Eltepu's innovative work in immunomodulating technologies has positioned him as a key figure in the field. His patents and collaborations reflect his commitment to advancing medical science and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…